证券代码：688716 证券简称：中研股份 公告编号：2025-044 吉林省中研高分子材料股份有限公司 关于召开 2025 年第三季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2025 年 12 月 02 日（星期二）13:00-14:00 会议召开地点：上海证券交易所上证路演中心（网址：https: //roadshow.sseinfo.com/） 会议召开方式：上海证券交易所上证路演中心网络互动 投资者可于 2025 年 11 月 25 日（星期三）至 12 月 01 日（星 期一）16:00 前登录上海证券交易所上证路演中心网站首页点击"提 问预征集"栏目或通过公司邮箱 jlzypeek@126.com 进行提问。公司 将在说明会上对投资者普遍关注的问题进行回答。 吉林省中研高分子材料股份有限公司（以下简称"公司"）已 于 2025 年 10 月 31 日发布公司 2025 年第三季度报告，为便于广大投 资者更全面深入地了解公司 2025 年第三季度经营成果、财务状 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 吉林省中研高分子材料股份有限公司（以下简称"公司"）第四届董事会 第六次会议的通知于 2025 年 10 月 17 日以专人送达等方式送达全体董事，会议 于 2025 年 10 月 30 日以现场结合通讯的方式召开。本次会议由董事长谢怀杰先 生主持，会议应出席董事 8 人，实际出席董事 8 人。本次会议的召集、召开和 表决程序符合《中华人民共和国公司法》（以下简称"《公司法》"）《中华 人民共和国证券法》（以下简称"《证券法》"）《上海证券交易所科创板股 票上市规则》等相关法律、行政法规、规范性文件及《吉林省中研高分子材料 股份有限公司章程》（以下简称"《公司章程》"）的有关规定。 证券代码：688716 证券简称：中研股份 公告编号：2025-043 吉林省中研高分子材料股份有限公司 第四届董事会第六次会议决议公告 二、董事会会议审议情况 本次会议经全体董事表决，形成决议如下： （一）审议通过《关于公司<2025 年第三季度报告>的议案》 本议案在提 ...

Financial Performance - The company's operating revenue for Q3 2025 was ¥75,748,830.82, representing a year-on-year increase of 28.04%[3]. - The total profit for the period decreased by 61.06% to ¥5,375,122.06, while the net profit attributable to shareholders fell by 72.43% to ¥3,400,007.56[3][7]. - The net profit excluding non-recurring gains and losses for the period was ¥1,496,328.53, a decrease of 54.58%[3][7]. - The total profit for the year-to-date period decreased by 58.90% to ¥13,477,974.50[3][7]. - Net profit for the first three quarters of 2025 was ¥10,426,941.04, a significant decrease of 65.0% from ¥29,851,649.60 in the same period of 2024[18]. - Operating profit for the first three quarters of 2025 was ¥13,872,772.51, down 57.9% from ¥32,927,204.45 in 2024[18]. Cash Flow - The net cash flow from operating activities was negative at -¥40,179,573.53, a decline of 412.09% compared to the same period last year[3][8]. - Cash flow from operating activities for the first three quarters of 2025 was negative at -¥56,667,190.81, compared to a positive cash flow of ¥16,904,544.44 in 2024[22]. - The net cash flow from investing activities was -$94.58 million, a decrease from -$123.85 million year-over-year[23]. - The total cash inflow from financing activities was $49.31 million, compared to $59.27 million in the previous period[23]. - The net cash flow from financing activities was $24.23 million, down from $34.90 million year-over-year[23]. - The net increase in cash and cash equivalents was -$127.02 million, compared to -$72.05 million in the previous period[23]. - The ending balance of cash and cash equivalents was $425.08 million, down from $543.82 million year-over-year[23]. Research and Development - Research and development (R&D) expenses totaled ¥13,894,330.78, an increase of 87.07%, accounting for 18.34% of operating revenue, up 46.14 percentage points[4][8]. - The company emphasized its commitment to increasing R&D investment to support future growth and project development[7]. - Research and development expenses increased to ¥29,434,542.91 in 2025, compared to ¥21,097,214.47 in 2024, marking an increase of 39.5%[18]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,354,986,538.47, showing a slight increase of 0.037% from the previous year[4]. - Total current assets as of September 30, 2025, amount to ¥901,108,555.51, a decrease from ¥988,891,466.09 as of December 31, 2024[13]. - Total liabilities as of September 30, 2025, are ¥110,543,575.37, down from ¥121,308,317.65[14]. - Total liabilities as of the end of the reporting period were ¥172,405,620.57, a decrease from ¥182,330,870.90 in the previous year[15]. - Total equity attributable to shareholders increased to ¥1,182,580,917.90 from ¥1,172,153,976.86, reflecting a growth of 0.4%[15]. - Long-term assets increased to ¥453,877,982.96 from ¥365,593,381.67[14]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 17,036[10]. - The largest shareholder, Xie Huaijie, holds 36,928,382 shares, accounting for 30.35% of total shares[10]. - The company has no significant changes in major shareholders due to margin trading activities[11]. Other Information - The company has not reported any significant new strategies or product developments during the reporting period[12]. - There are no applicable audit opinions for the quarterly financial statements[12]. - The company reported a basic earnings per share of ¥0.03, down 70.00% compared to the same period last year[3][8]. - The company reported a basic earnings per share of ¥0.09 for the first three quarters of 2025, down from ¥0.25 in 2024[19].

Company Overview - Zhongyan Co., Ltd. focuses on the research, production, and sales of PEEK, becoming the largest producer of PEEK in China [4] - The company was officially listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on September 20, 2023, and is the fourth global company with an annual production capacity of PEEK reaching the kiloton level [4] - Currently, the company has an annual production capacity of 1,000 tons of PEEK, with an additional 5,000 tons of deep processing products expected to be operational by September 2026 [4] Industry Landscape - The global PEEK supply shows a "one strong, many strong" pattern, with current global PEEK production capacity at approximately 21,000 tons per year and planned new capacity of about 2,050 tons per year, mainly from China [5] - The PEEK market in China is projected to grow from 1.496 billion yuan in 2022 to 2.838 billion yuan by 2027, with a CAGR of approximately 13.7% [5] Market Opportunities - The lightweight industry trend presents significant opportunities for PEEK, which is a high-performance lightweight material [6] - PEEK is widely used in high-tech industries and harsh environments, making product quality stability crucial to avoid safety production accidents [6] - The company has a strong technological foundation, with significant advantages in PEEK resin quality, including melt stability, appropriate melt index, viscosity balance, batch stability, and excellent crystallization performance [6]

Core Viewpoint - The company has been deeply engaged in the PEEK business for nearly two decades, emphasizing innovation-driven development and establishing a complete innovation ecosystem from basic research to industrial application in the PEEK materials field [1] Group 1 - The company has accumulated certain advantages in technology research and development, product offerings, management team, and brand reputation in the PEEK materials sector [1]

Core Viewpoint - The company emphasizes its focus on various downstream application fields for its PEEK products, including automotive, electronic information, high-end manufacturing, energy, healthcare, and aerospace industries [1] Group 1 - The company has not yet directly engaged in the humanoid robot application field [1] - The company currently lacks production capabilities for humanoid robot components [1]

Core Insights - The company is expanding its overseas market presence through a multi-dimensional strategic collaboration, primarily focusing on the Asia-Pacific region, including Japan and South Korea, with a direct sales approach [1] - In the first half of the year, the company has made strides in entering the European market by partnering with local warehousing and logistics providers to establish a European warehousing center, which facilitates localized inventory management and rapid delivery, effectively shortening service cycles [1]

Group 1 - The core inquiry from investors is whether Zhongyan Co., Ltd. is the exclusive supplier of joint bearings for Tesla's Optimus humanoid robot [2] - Zhongyan Co., Ltd. confirmed on the investor interaction platform that its PEEK products are utilized in various downstream applications, including automotive, electronics, high-end manufacturing, energy, healthcare, and aerospace industries [2] - The company emphasized that it has not yet directly engaged in the humanoid robot application field and currently lacks the production capacity for humanoid robot components [2]

Core Viewpoint - Zhongyan Co., Ltd. has clarified that it is not currently involved in the production of components for humanoid robots, despite speculation about its exclusive supply of joint bearings for Tesla's Optimus robot [1] Company Summary - Zhongyan Co., Ltd. (688716) responded to inquiries regarding its involvement with Tesla's humanoid robot, stating that it has not yet entered the humanoid robot application field [1] - The company emphasizes its focus on downstream application areas with significant potential, including humanoid robots, but currently lacks production capabilities for humanoid robot components [1]

Core Viewpoint - The company emphasizes the potential of its PEEK products in various downstream applications, including automotive, electronics, high-end manufacturing, energy, healthcare, and aerospace industries, while noting its current lack of involvement in humanoid robotics [1] Summary by Categories Downstream Applications - The company's PEEK products are applicable in multiple industries such as automotive, electronics, high-end manufacturing, energy, healthcare, and aerospace [1] Humanoid Robotics - The company recognizes the promising prospects of humanoid robotics as a downstream application area but has not yet engaged in this field and lacks production capabilities for humanoid robot components [1]